Recursion
PublicRecursion (NASDAQ: RXRX) is a clinical-stage TechBio company that decodes biology to radically improve lives. It advances a portfolio of investigational medicines across oncology, rare disease, neuroscience, and immunology, enabled by the Recursion OS — an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system. The platform leverages proprietary multimodal data, purpose-built AI models, and automated laboratories to translate complex science into medicines faster and at scale.
